INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72 | +53.2% | 2,263 | +95.9% | 0.02% | +40.0% |
| Q2 2023 | $47 | +6.8% | 1,155 | -3.1% | 0.02% | 0.0% |
| Q1 2023 | $44 | +33.3% | 1,192 | +24.9% | 0.02% | +15.4% |
| Q4 2022 | $33 | -99.9% | 954 | +10.2% | 0.01% | -35.0% |
| Q3 2022 | $48,000 | +500.0% | 866 | +462.3% | 0.02% | +566.7% |
| Q2 2022 | $8,000 | -27.3% | 154 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $11,000 | -38.9% | 154 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | – | 154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |